Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk B | Copenhagen | Healthcare | Pharmaceuticals | DKK 3.88T | 44x | 0.95 | DKK 873.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Coloplast | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 200.42B | 39.9x | -45.52 | DKK 889.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Genmab | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 123.31B | 23.2x | 5.95 | DKK 1,943 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Zealand Pharma | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 62.63B | -73x | -1.73 | DKK 889 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Demant | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 55.82B | 31.9x | -1.7 | DKK 256.60 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
H Lundbeck AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 39.57B | 14.8x | 13.32 | DKK 35.95 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
H Lundbeck B | Copenhagen | Healthcare | Pharmaceuticals | DKK 39.57B | 14.8x | 13.3 | DKK 41.54 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Ambu | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 36.32B | 100.9x | 0.16 | DKK 136.30 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
ALK-Abello B | Copenhagen | Healthcare | Pharmaceuticals | DKK 33.27B | 58.6x | 0.87 | DKK 149.70 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Bavarian Nordic | Copenhagen | Healthcare | Pharmaceuticals | DKK 14.06B | 14.3x | 0.07 | DKK 181 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Embla Medical hf | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 13.23B | 31.6x | 1.13 | DKK 31 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Gubra AS | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 9.19B | -102.2x | 0.23 | DKK 644 | 14.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
ChemoMetec | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 6.74B | 46.8x | -2.25 | DKK 387 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
BioPorto | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 966.73M | -15.4x | -0.5 | DKK 2.27 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Bactiquant AS | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 164.48M | DKK 7 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Scandinavian Medical Solutions AS | Copenhagen | Healthcare | Healthcare Equipment & Supplies | DKK 159.51M | 30x | -0.46 | DKK 6.10 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Stenocare AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 72.33M | -4.8x | -0.12 | DKK 3.64 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
ViroGates | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 41.25M | -3x | -0.1 | DKK 6.40 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Orphazyme | Copenhagen | Healthcare | Biotechnology & Medical Research | DKK 30.51M | -1.2x | 0.01 | DKK 863.90 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |